Macquarie Group LTD Verastem, Inc. Transaction History

Macquarie Group LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 11, 2020	SELL	$1.69 - $4.2 $37,200 - $92,450	-22,012 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$1.26 - $3.38 $27,735 - $74,400	22,012 New	22,012 $58,000
Q1 2018 May 11, 2018	SELL	$2.92 - $3.81 $21,024 - $27,432	-7,200 Closed	0 $0
Q4 2017 Feb 15, 2018	BUY	$2.99 - $4.85 $21,528 - $34,920	7,200	7,200 $22,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $838M
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

Stay updated on Macquarie Group LTD with notifications on news.